Mutual of America Capital Management LLC Sells 1,732 Shares of LivaNova PLC (NASDAQ:LIVN)

Mutual of America Capital Management LLC lowered its position in LivaNova PLC (NASDAQ:LIVN) by 4.9% in the fourth quarter, Holdings Channel.com reports. The fund owned 33,297 shares of the company’s stock after selling 1,732 shares during the period. Mutual of America Capital Management LLC’s holdings in LivaNova were worth $1,723,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors also recently modified their holdings of the company. Lazard Asset Management LLC acquired a new stake in LivaNova during the second quarter worth $46,000. Headlands Technologies LLC acquired a new stake in shares of LivaNova during the 3rd quarter valued at about $72,000. Point72 Middle East FZE bought a new stake in LivaNova in the fourth quarter valued at about $72,000. Picton Mahoney Asset Management acquired a new stake in LivaNova during the third quarter valued at approximately $91,000. Finally, PNC Financial Services Group Inc. grew its stake in shares of LivaNova by 16.7% in the 2nd quarter. PNC Financial Services Group Inc. now owns 2,853 shares of the company’s stock valued at $147,000 after purchasing an additional 408 shares during the period. Institutional investors and hedge funds own 97.64% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms recently commented on LIVN. Needham & Company LLC restated a “buy” rating and set a $72.00 target price on shares of LivaNova in a research report on Wednesday, March 20th. Robert W. Baird boosted their target price on shares of LivaNova from $56.00 to $62.00 and gave the company a “neutral” rating in a research note on Thursday, February 22nd. StockNews.com lowered shares of LivaNova from a “buy” rating to a “hold” rating in a report on Wednesday, April 17th. Mizuho reissued a “buy” rating and set a $75.00 price target on shares of LivaNova in a report on Wednesday, March 27th. Finally, Barclays upped their price objective on shares of LivaNova from $57.00 to $61.00 and gave the stock an “equal weight” rating in a research note on Monday, February 26th. Four analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $64.40.

LivaNova Stock Down 0.8 %

Shares of NASDAQ:LIVN opened at $52.33 on Monday. The company has a quick ratio of 2.51, a current ratio of 2.95 and a debt-to-equity ratio of 0.44. The firm has a market cap of $2.82 billion, a P/E ratio of 163.54 and a beta of 0.89. LivaNova PLC has a 12 month low of $42.75 and a 12 month high of $59.86. The company’s 50-day moving average price is $53.58 and its two-hundred day moving average price is $50.52.

LivaNova (NASDAQ:LIVN) last announced its earnings results on Wednesday, February 21st. The company reported $0.87 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.77 by $0.10. The company had revenue of $310.10 million for the quarter, compared to analyst estimates of $287.65 million. LivaNova had a net margin of 1.53% and a return on equity of 12.23%. LivaNova’s quarterly revenue was up 12.8% on a year-over-year basis. During the same period in the prior year, the business earned $0.81 earnings per share. As a group, research analysts forecast that LivaNova PLC will post 3.01 EPS for the current fiscal year.

About LivaNova

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.